Scientists from Tufts create weight-loss drug dubbed 'next Ozempic' that's twice as effective and has fewer side effects (affects not only GLP-1 and GIP, but also glucagon and peptide YY)
Implantable device could save diabetes patients from dangerously low blood sugar | The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.
.jpg)
